Pop Nathalie, Igel Patrick, Brennauer Albert, Cabrele Chiara, Bernhardt G Nther, Seifert Roland, Buschauer Armin
Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Germany.
J Recept Signal Transduct Res. 2011 Aug;31(4):271-85. doi: 10.3109/10799893.2011.583253.
The four functionally expressed human neuropeptide Y receptor subtypes (hY(1)R, hY(2)R, hY(4)R, hY(5)R) belong to class A of the G-protein-coupled receptors (GPCRs) and interact with pertussis toxin-sensitive G(i/o)-proteins. The number of small molecules described as ligands for hY(1)R and hY(5)R exceeds by far those for hY(2)R. Potent non-peptidergic ligands for the hY(4)R are not available so far. Here, we report on the functional reconstitution of the hY(2)R and the hY(4)R in Sf9 insect cells using the baculovirus system. Sf9 cells were genetically engineered by infection with up to four different baculoviruses, combining the receptors with G-proteins of the G(i/o) family and regulators of G-protein signaling (RGS) proteins to improve signal-to-noise ratio. In steady-state GTPase assays, using pNPY (Y(2)) and hPP (Y(4)), the GPCRs coupled to various G(i)/G(o)-proteins and both, RGS4 and GAIP, enhanced the signals. Co-expression systems hY(2)R + G?(i2) and hY(4)R + G?(i2)/G?(o) + RGS4, combined with G?(1)?(2), yielded best signal-to-noise ratios. hY(2)R function was validated using both agonistic peptides (NPY, PYY, NPY(13?36)) and selective non-peptidergic antagonists (BIIE0246 and derivatives), whereas the hY(4)R model was characterized with peptidergic agonists (PP, NPY, GW1229, and BW1911U90). Tunicamycin inhibited receptor N-glycosylation diminished NPY signals at hY(2)R and abolished hY(4)R function. Investigations with monovalent salts showed sensitivity of hY(4)R toward Na(+), revealing moderate constitutive activity. After validation, an acylguanidine (UR-PI284) was identified as a weak non-peptide Y(4)R antagonist. In summary, the established steady-state GTPase assays provide sensitive test systems for the characterization of Y(2) and Y(4) receptor ligands.
四种具有功能活性的人神经肽Y受体亚型(hY(1)R、hY(2)R、hY(4)R、hY(5)R)属于G蛋白偶联受体(GPCRs)A类,与百日咳毒素敏感的G(i/o)蛋白相互作用。被描述为hY(1)R和hY(5)R配体的小分子数量远远超过hY(2)R的。到目前为止,还没有针对hY(4)R的强效非肽类配体。在此,我们报道了使用杆状病毒系统在Sf9昆虫细胞中对hY(2)R和hY(4)R进行功能重建。通过用多达四种不同的杆状病毒感染对Sf9细胞进行基因工程改造,将受体与G(i/o)家族的G蛋白以及G蛋白信号调节剂(RGS)蛋白结合,以提高信噪比。在稳态GTP酶分析中,使用pNPY(Y(2))和hPP(Y(4)),这些GPCR与各种G(i)/G(o)蛋白偶联,并且RGS4和GAIP都增强了信号。共表达系统hY(2)R + G?(i2)和hY(4)R + G?(i2)/G?(o) + RGS4,与G?(1)?(2)结合,产生了最佳的信噪比。使用激动性肽(NPY、PYY、NPY(13?36))和选择性非肽类拮抗剂(BIIE0246及其衍生物)验证了hY(2)R的功能,而hY(4)R模型则用肽类激动剂(PP、NPY、GW1229和BW1911U90)进行了表征。衣霉素抑制受体N-糖基化减少了hY(2)R处的NPY信号并消除了hY(4)R的功能。单价盐的研究表明hY(4)R对Na(+)敏感,揭示了适度的组成性活性。验证后,一种酰基胍(UR-PI284)被鉴定为一种弱的非肽Y(4)R拮抗剂。总之,所建立的稳态GTP酶分析为Y(2)和Y(4)受体配体的表征提供了灵敏的测试系统。